CN Patent

CN104586802B — 一种含有索菲布韦的药物组合物

Assigned to CHANGCHUN HAIYUE PHARMACEUTICAL Co Ltd · Expires 2018-01-16 · 8y expired

What this patent protects

本发明属于医药技术领域，具体涉及一种含有索菲布韦的药物组合物，所述的药物组合物含有索菲布韦、填充剂、表面活性剂。本发明的本发明的产品稳定性好，溶出完全，具有更加优秀的产品质量；本发明的产品生产操作简单易行，适合于工业生产。

USPTO Abstract

本发明属于医药技术领域，具体涉及一种含有索菲布韦的药物组合物，所述的药物组合物含有索菲布韦、填充剂、表面活性剂。本发明的本发明的产品稳定性好，溶出完全，具有更加优秀的产品质量；本发明的产品生产操作简单易行，适合于工业生产。

Drugs covered by this patent

Patent Metadata

Patent number: CN104586802B
Jurisdiction: CN
Classification: —
Expires: 2018-01-16
Drug substance claim: No
Drug product claim: No
Assignee: CHANGCHUN HAIYUE PHARMACEUTICAL Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.